Рет қаралды 3,188
Breakthrough HIV vaccine trial raises hopes of AIDS treatment
In the phase 1 clinical trial, 20 healthy, HIV-negative individuals received either two or three doses of the experimental vaccine.
In Short
After just two immunizations, the vaccine triggered a 95% serum response rate
Broadly neutralising antibodies were induced within weeks of the initial doses
The trial was halted due to a non-life-threatening allergic reaction
In a major step forward for HIV vaccine development, researchers at the Duke Human Vaccine Institute have successfully induced broadly neutralizing antibodies against HIV through vaccination for the first time.
Thank you for watching the video, wish you health and happiness!
Subscribe to the channel at: goo.gl/iz6xA4
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
If you have any questions, please contact us by email: dauhieubenh2017@gmail.com
Sincerely thank you!
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
Sign up: / @hivaidsprevention
Facebook: / hivaids2024
Twitter: / daubenh
Gmail: dauhieubenh2017@gmail.com